Thomas A. Long

A Prospective, Multi-Institutional Diagnostic Trial to Determine Pathologist Accuracy in Estimation of Percentage of Malignant Cells

Hollis Viray, Kevin Li, Thomas A. Long et al. · Archives of Pathology & Laboratory Medicine · 2013 · 106 citations

Medicine, Oncology, Pathology +9

Comparison of Laboratory-Developed Tests and FDA-Approved Assays for <i>BRAF, EGFR,</i> and <i>KRAS</i> Testing

Annette S. Kim, Angela N. Bartley, Julia A. Bridge et al. · JAMA Oncology · 2017 · 36 citations · Full text

Medicine, Oncology, Pathology +15

Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on BRAF, EGFR, and KRAS Proficiency Testing Samples

Lea F. Surrey, Fredrick D. Oakley, Jason D. Merker et al. · Archives of Pathology & Laboratory Medicine · 2019 · 17 citations · Full text

Medicine, Oncology, Pathology +17

Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee

Joel T. Moncur, Angela N. Bartley, Julia A. Bridge et al. · Archives of Pathology & Laboratory Medicine · 2019 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing

Ann M. Moyer, Gwendolyn A. McMillin, Thomas A. Long et al. · Archives of Pathology & Laboratory Medicine · 2020 · 12 citations · Full text

Medicine, Genetics, Pharmacology +15